The Src Homology-2 Domains (SH2 Domains) of the Protein Tyrosine Kinase p56 lck Structure, Mechanism and Drug Design

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|1|4|365-386

ISSN： 1389-4501

Source： Current Drug Targets, Vol.1, Iss.4, 2000-01, pp. : 365-386

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antagonists of the Src Homology 2 (SH2) Domains of Grb2, Src, Lck and ZAP-70

By  

Current Medicinal Chemistry, Vol. 8, Iss. 13, 2001-11 ,pp. : 1589-1604

Bentham Science Publishers

Access to resources Recommend Favorite

4-Thiophenoxy-N-(3,4,5-Trialkoxyphenyl)Pyrimidine-2-Amines as Potent and Selective Inhibitors of the T-Cell Tyrosine Kinase p56lck

By  

Current Medicinal Chemistry, Vol. 11, Iss. 6, 2004-03 ,pp. : 747-753

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in the Development of Inhibitors of SH2 Domains

By  

Current Pharmaceutical Design, Vol. 6, Iss. 1, 2000-01 ,pp. : 59-98

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-based Design of Compounds Inhibiting Grb2-SH2 Mediated Protein-protein Interactions in Signal Transduction Pathways

By  

Current Pharmaceutical Design, Vol. 6, Iss. 18, 2000-12 ,pp. : 1777-1796

Bentham Science Publishers

Access to resources Recommend Favorite

Design of Selective Inhibitors of Tyrosine Kinase 2

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 7, 2005-11 ,pp. : 507-515

Bentham Science Publishers

Access to resources Recommend Favorite